FLAM
First Light Asset Management Portfolio holdings
AUM
$771M
This Quarter Return
+22.3%
1 Year Return
+33.17%
3 Year Return
+208.13%
5 Year Return
+426.73%
10 Year Return
+3,318.8%
AUM
$455M
AUM Growth
+$455M
(+25%)
Cap. Flow
+$43.9M
Cap. Flow
% of AUM
9.65%
Top 10 Holdings %
Top 10 Hldgs %
56.91%
Holding
55
New
3
Increased
34
Reduced
5
Closed
3
Top Buys
| 1 |
Tandem Diabetes Care
TNDM
|
$23.5M |
| 2 |
SHPG
Shire pic
SHPG
|
$15M |
| 3 |
NeoGenomics
NEO
|
$7.45M |
| 4 |
NVTR
Nuvectra Corporation Common Stock
NVTR
|
$5.39M |
| 5 |
Harvard Bioscience
HBIO
|
$4.01M |
Top Sells
| 1 |
ENTL
Entellus Medical, Inc. Common Stock
ENTL
|
$16.4M |
| 2 |
Nektar Therapeutics
NKTR
|
$5.49M |
| 3 |
QuidelOrtho
QDEL
|
$2.27M |
| 4 |
BLUE
bluebird bio
BLUE
|
$2.12M |
| 5 |
Codexis
CDXS
|
$1.88M |
Sector Composition
| 1 | Healthcare | 84.88% |
| 2 | Communication Services | 4.24% |
| 3 | Energy | 0.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
NXTM
26
DELISTED
NxStage Medical Inc.
NXTM
| $4.81M | 1.06% |
193,339
+669
| +0.3% | +$16.6K |
|
27
Veracyte
VCYT
$2.41B
| $4.72M | 1.04% |
849,566
+58,229
| +7% | +$324K |
|
|
LHCG
28
DELISTED
LHC Group LLC
LHCG
| $4.43M | 0.97% |
71,999
+3,192
| +5% | +$196K |
|
|
BLUE
29
DELISTED
bluebird bio
BLUE
| $4.34M | 0.95% |
25,416
-12,422
| -33% | -$2.12M |
|
|
30
QuidelOrtho
QDEL
$1.87B
| $3.94M | 0.87% |
76,068
-43,833
| -37% | -$2.27M |
|
31
Vertex Pharmaceuticals
VRTX
$102B
| $3.82M | 0.84% |
23,429
+372
| +2% | +$60.6K |
|
|
TLGT
32
DELISTED
Teligent, Inc
TLGT
| $3.7M | 0.81% |
1,100,823
-402,304
| -27% | -$1.35M |
|
|
STRM
33
DELISTED
Streamline Health Solutions
STRM
| $3.49M | 0.77% |
1,897,681
+522,637
| +38% | +$962K |
|
34
BioMarin Pharmaceuticals
BMRN
$11.3B
| $2.58M | 0.57% |
31,850
+637
| +2% | +$51.6K |
|
35
iShares Biotechnology ETF
IBB
$5.68B
| $2.27M | 0.5% |
21,291
| – | – |
|
36
IRIDEX
IRIX
$23.6M
| $2.22M | 0.49% |
387,687
+69,888
| +22% | +$400K |
|
|
XLVS
37
DELISTED
POWERSHARES S&P SMALLCAP HEALTH CARE PORTFOLIO
XLVS
| $1.93M | 0.42% |
17,285
| – | – |
|
38
Ionis Pharmaceuticals
IONS
$9.64B
| $1.87M | 0.41% |
42,464
+617
| +1% | +$27.2K |
|
39
Alkermes
ALKS
$4.95B
| $1.75M | 0.38% |
30,211
+678
| +2% | +$39.3K |
|
40
OrthoPediatrics
KIDS
$524M
| $1.75M | 0.38% |
+116,185
| New | +$1.75M |
|
41
LeMaitre Vascular
LMAT
$2.14B
| $1.7M | 0.37% |
46,910
+791
| +2% | +$28.7K |
|
42
Health Care Select Sector SPDR Fund
XLV
$33.8B
| $1.49M | 0.33% |
18,241
| – | – |
|
43
iShares US Medical Devices ETF
IHI
$4.27B
| $1.4M | 0.31% |
7,580
| – | – |
|
|
ENZ
44
DELISTED
Enzo Biochem, Inc.
ENZ
| $1.38M | 0.3% |
251,002
+13,948
| +6% | +$76.4K |
|
|
CELG
45
DELISTED
Celgene Corp
CELG
| $1.24M | 0.27% |
13,852
+340
| +3% | +$30.3K |
|
46
AbbVie
ABBV
$374B
| $394K | 0.09% |
4,159
| – | – |
|
|
DYNT
47
DELISTED
Dynatronics Corp
DYNT
| $321K | 0.07% |
106,985
+2,606
| +2% | +$7.82K |
|
48
Pfizer
PFE
$141B
| $304K | 0.07% |
8,558
| – | – |
|
49
Novartis
NVS
$248B
| $289K | 0.06% |
3,572
| – | – |
|
50
Johnson & Johnson
JNJ
$429B
| $280K | 0.06% |
2,183
| – | – |
|